Please try another search
GLG Pharma S.A. engages in the research and development in the field of biotechnology. It is developing a targeted therapy for TNBC; and tests based on immunochemical methods for rapid diagnosis of TNBC tumor and monitoring the effectiveness of therapy. The company also engages in the development of diagnostic methods in the field of oncology. The company was formerly known as M10 Spólka Akcyjna and changed its name to GLG Pharma S.A. in September 2015. The company is based in Wroclaw, Poland.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review